Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Levcycloserine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cycloserine SCHEMBL34322 | 1.00 | — | — | |
| Cycloserine SCHEMBL8681117 | 1.00 | BLM (1.00) | — | |
| Cycloserine SCHEMBL8681114 | 1.00 | BLM (1.00) | — | |
| Cycloserine SCHEMBL34323 | 1.00 | — | — | |
| Cycloserine SCHEMBL18584681 | 1.00 | BLM (1.00) | — | |
| Cycloserine SCHEMBL6571320 | 0.97 | — | — | |
| Cycloserine SCHEMBL429258 | 0.97 | — | — | |
| Cycloserine SCHEMBL10448776 | 0.97 | — | — | |
| Cycloserine SCHEMBL5351530 | 0.89 | BLM (0.79) | — | |
| Cycloserine SCHEMBL3921591 | 0.89 | BLM (0.79) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2889 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719059-A1 | INCREASED PALATABILITY OF INSECTICIDAL INSECT BAITS | Bio Logic Crop Science, S.L. (ES) | 2026-04-08 | — | — | EP | claimed |
| EP-4702978-A1 | AGENT FOR TREATING OR PREVENTING AMYOTROPHIC LATERAL SCLEROSIS | Socium Inc. (JP) | 2026-03-04 | — | — | EP | claimed |
| WO-2026041700-A1 | PROCESS FOR PREPARING OXAZOLE COMPOUNDS | BASF SE (DE) | 2026-02-26 | — | — | WO | claimed |
| US-20260027140-A1 | COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA | ATOPIC MEDICAL INC (US) | 2026-01-29 | — | — | US | claimed |
| US-20250367153-A1 | COMPOSITION AND APPLICATION THEREOF | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2025-12-04 | — | — | US | claimed |
| EP-4583860-A1 | INHIBITORS OF THE CERAMIDE METABOLIC PATHWAY FOR OVERCOMING IMMUNOTHERAPY RESISTANCE IN CANCER | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-07-16 | — | — | EP | claimed |
| US-20250222117-A1 | COMPOUND COMPRISING RALTITREXED OR 5-MTHF LINKED TO A THERAPEUTIC AGENT, COMPOSITION, AND METHOD OF USE | PURDUE RESEARCH FOUNDATION | 2025-07-10 | — | — | US | claimed |
| CN-115944627-B | Pharmaceutical composition for treating breast cancer | 山西医科大学 | 2025-03-14 | — | — | CN | claimed |
| CN-111526873-B | For modulating microbial colonization substituted diphenylacetylenes of (2) | 生物曼迪克斯有限责任公司 | 2025-03-04 | — | — | CN | claimed |
| CN-119212703-A | Therapeutic or prophylactic agent for amyotrophic lateral sclerosis | 寿协株式会社 | 2024-12-27 | — | — | CN | claimed |
| US-6190894-B1 | APPLYING INHIBITORS OF BIOSYNTHESIS OR DEGRADATION, DEGRADATION ENZYMES, AND/OR INHIBITORS AND ACTIVATORS OF METABOLIC ENZYMES; FOR TOPICAL ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE SUBSTANCES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-02-20 | — | — | US | claimed |
| CN-1264430-A | Betaines as adjuvants to susceptibility testing and antimicrobial therapy | INTEGRATED RES TECHNOLOGY PLC (US) | 2000-08-23 | — | — | CN | claimed |
| CN-1248923-A | Device and method for delivery of drugs and genes using electroporation route | GENETRONICS INC (US) | 2000-03-29 | — | — | CN | claimed |
| WO-1998017253-A1 | METHOD AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-04-30 | — | — | WO | claimed |
| EP-0764017-A4 | METHODS AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION | CELLEGY PHARMA INC (US) | 1997-08-06 | — | — | EP | claimed |
| EP-0764017-A1 | METHODS AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION | CELLEGY PHARMACEUTICALS, INC. (US) | 1997-03-26 | — | — | EP | claimed |
| WO-1996030381-A1 | IMMUNOSUPPRESSIVE AGENTS | NOVO NORDISK A/S (DK) | 1996-10-03 | — | — | WO | claimed |
| WO-1996013263-A2 | METHODS OF TREATMENT OF VIRAL DISEASE WITH INHIBITORS OF SPHINGOLIPID BIOSYNTHESIS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1996-05-09 | — | — | WO | claimed |
| WO-1994021230-A1 | METHOD AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION | CELLEGY PHARMACEUTICALS, INC. (US) | 1994-09-29 | — | — | WO | claimed |
| US-5302609-A | Administering synthetase inhibitors | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1994-04-12 | — | — | US | claimed |